GGrantIndex
← Search

Proteomics

$7,797P30FY2018CANIH

Stanford University, Stanford CA

Investigators

Linked publications, trials & patents

Paper 39574895Paper 39534431Paper 39506045Paper 39378093Paper 39257774Paper 39179931Paper 39163262Paper 39132489Paper 39042439Paper 38997156Paper 38996463Paper 38987048Paper 38968138Paper 38838737Paper 38810650Paper 38746193Paper 38563850Paper 38496616Paper 38496500Paper 38408498Paper 38387457Paper 38278150Paper 38273211Paper 38262408Paper 38260330Paper 38200310Paper 38154193Paper 38096469Paper 37963187Paper 37917579Paper 37882771Paper 37812494Paper 37743567Paper 37667254Paper 37662553Paper 37534980Paper 37532139Paper 37527449Paper 37398193Paper 37244414Paper 37196642Paper 37184546Paper 37162847Paper 36999999Paper 36993756Paper 36813894Paper 36747642Paper 36734849Paper 36729432Paper 36729074Paper 36719070Paper 36717409Paper 36711732Paper 36701540Paper 36652552Paper 36640300Paper 36635501Paper 36624348Trial NCT05220254Trial NCT03733210Trial NCT03405142Trial NCT03241940Trial NCT03179449Trial NCT02855086Trial NCT02805075Trial NCT02762266Trial NCT02736578Trial NCT02735356Trial NCT02699723Trial NCT02695628Trial NCT02690948Trial NCT02683824Trial NCT02635074Trial NCT02624518Trial NCT02599194Trial NCT02581787Trial NCT02488070Trial NCT02440308Trial NCT02432118Trial NCT02429804Trial NCT02415608Trial NCT02401347Trial NCT02215928Trial NCT02210858Trial NCT02203565Trial NCT02184533Trial NCT02175745Trial NCT02166983Trial NCT02058550Trial NCT02030405Trial NCT02019069Trial NCT01977677Trial NCT01943188Trial NCT01928030Trial NCT01926990Trial NCT01908166Trial NCT01904643Trial NCT01898403Trial NCT01893892Trial NCT01868503

Abstract

The Proteomics Shared Resource offers state-of-the-art, user-friendly mass spectrometry-based resources to support Cancer Institute members. In addition to providing facilities and services, the Shared Resource enables education, methods development and new applications, designed to meet the rapidly evolving needs of cancer researchers. The Shared Resource operates under the direction of Dr. Allis Chien, with oversight by an interdisciplinary faculty advisory committee. It currently occupies 2200 sq ft of space in a convenient, accessible central campus location, and employs six staff scientists in addition to Dr. Chien. The Shared Resource houses 14 mass spectrometers and associated instrumentation; these include single quadrupole, ion trap, triple quadrupole, Q-TOF and Orbitrap mass spectrometers, with appropriate chromatography front ends. In-house proteomics data processing capabilities include Proteome Discoverer, Mascot, Scaffold, Byonic, Skyline, PEAKS and MaxQuant. Annual operating costs are $1.2M. The facility operates on a cost-recovery basis, with ongoing expenses recovered primarily through user fees. Since 2009, over 80 SCI members have used the Shared Resource. Future goals include the implementation of newly installed MS instrumentation, expansion of protein network analysis and quantitative proteomics services, and enhancement of bioinformatics capabilities. Services provided include: peptide and protein identification, characterization of post-translational modifications, protein quantitation, biomarker verification and metabolic studies. In addition, the Proteomics Shared Resource seeks to educate the Stanford research community on how their research can be enhanced and improved by MS methods. With the availability of quality on campus mass spectrometry support, researchers become more involved with experimental design, data analysis, and results interpretation, developing a real understanding of the MS results. Close proximity between the facility and campus research laboratories promotes interactions between researchers and the Proteomics team. These interactions are mutually beneficial and can lead to new paths of research investigation. Stanford researchers have come to expect and value this type of support from the Shared Resource; Cancer Institute members use this Shared Resource frequently, with half of all usage in FY2014 from members.

View original record on NIH RePORTER →